MedMira Inc
TSXV:MIRView on OTC Pink - Current Information

  • LAST PRICE
    0.0750
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0750/ 20
  • Ask / Lots
    0.0800/ 50
  • Open / Previous Close
    0.0000 / 0.0750
  • Day Range
    ---
  • 52 Week Range
    0.0700
    0.1350
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Apr 1, 2024

      Show headlines and story abstract

    • 10:32PM ET on Monday Apr 01, 2024 by Accesswire
      Companies Mentioned: MMIRF

      HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024.

      Corporate update

      During Q2 FY2024, MedMira received the US FDA 510(k) clearance for the HIV-2 claim on the Reveal® G4 Rapid HIV-1/2 antibody test in the United States. This major milestone allows the Company to significantly grow its market share and revenue in the United States, while re-confirming its quality for its upcoming Clinical Laboratory Improvement Amendments (CLIA) waiver. The Reveal® G4 Rapid HIV-1/2 is the fastest high quality rapid test which is now available in the United States and can be sold to CLIA laboratories, clinics and hospitals.

    • 10:32PM ET on Monday Apr 01, 2024 by Dow Jones
      Companies Mentioned: MIR

      HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2024.

      Corporate update

Peers Headlines